Metastatic colorectal cancer: mechanisms and emerging therapeutics

AE Shin, FG Giancotti, AK Rustgi - Trends in pharmacological sciences, 2023 - cell.com
Metastatic colorectal cancer (mCRC) remains a lethal disease with an approximately 14% 5-
year survival rate. While early-stage colorectal cancer (CRC) can be cured by surgery with …

Metastatic colorectal cancer: mechanisms and emerging therapeutics.

AE Shin, FG Giancotti, AK Rustgi - Trends in Pharmacological …, 2023 - europepmc.org
Metastatic colorectal cancer (mCRC) remains a lethal disease with an approximately 14% 5-
year survival rate. While early-stage colorectal cancer (CRC) can be cured by surgery with …

[HTML][HTML] Metastatic colorectal cancer: mechanisms and emerging therapeutics

AE Shin, FG Giancotti, AK Rustgi - Trends in pharmacological …, 2023 - ncbi.nlm.nih.gov
Metastatic colorectal cancer (mCRC) remains a lethal disease with~ 14% of 5-year survival
rate. While early-stage CRC can be cured by surgery with or without adjuvant …

Metastatic colorectal cancer: mechanisms and emerging therapeutics

AE Shin, FG Giancotti… - Trends in …, 2023 - mdanderson.elsevierpure.com
Metastatic colorectal cancer (mCRC) remains a lethal disease with an approximately 14% 5-
year survival rate. While early-stage colorectal cancer (CRC) can be cured by surgery with …

Metastatic colorectal cancer: mechanisms and emerging therapeutics

AE Shin, FG Giancotti… - Trends in …, 2023 - pubmed.ncbi.nlm.nih.gov
Metastatic colorectal cancer (mCRC) remains a lethal disease with an approximately 14% 5-
year survival rate. While early-stage colorectal cancer (CRC) can be cured by surgery with …

Metastatic colorectal cancer: mechanisms and emerging therapeutics

AE Shin, FG Giancotti, AK Rustgi - Trends in Pharmacological Sciences, 2023 - Elsevier
Metastatic colorectal cancer (mCRC) remains a lethal disease with an approximately 14% 5-
year survival rate. While early-stage colorectal cancer (CRC) can be cured by surgery with …